Show pageOld revisionsBacklinksBack to top This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong. ====== Tuberous Sclerosis Complex ====== ====Main Features==== * Benign tumors of the brain, kidney, lung, heart and eyes. * One of the [[phakomatoses|phakomatoses]] ====Eye Findings==== * Retinal astrocytic hamartomas 34-75% of patients with TSC. * flat, translucent lesions, multinodular "mulberry" lesions, and transitional types. * usually non-progressive but can occasionally show subretinal fluid and progression. * Typically located along the arcades, adjacent to the optic nerve, or in the retinal periphery. * {{::retinal_hamartoma.jpg|}} * Retinal achromic patches 34% * hypopigmented areas similar to the hypomelanotic macules seen on the skin * Usually non-progressive and do not significantly affect vision * Refractive errors (myopia, hyperopia, and astigmatism), * Strabismus * Angiofibromas of the eyelids- rare * Coloboma- rare ====Other Findings==== * Brain (leading cause of morbidity) *subependymal nodules *cortical tubers *subependymal giant cell astrocytomas *Seizures *neuropsychiatric disorders/ developmental delay * Cardiac * rhabdomyomas * arrhythmias * Renal (leading cause of mortality) * benign renal angiomyolipomas * epithelial cysts * oncocytoma * Lungs * lymphangioleiomyomatosis * multifocal micro odular pheumonocyte hyperplasia * Dermatologic * Angiofibromatosis * Shagreen patches ====Etiology==== * Autosomal Dominant with near complete penetrance but variable expressivity due to Knudson's two-hit hypothesis * Mutations result in unregulated cell growth leading to hamartomas * Mutations in TSC1 (25%) * Encodes for gene hamartin- a tumor supressor gene * Chromosome 9q34 * Mutations in TSC2 (75%) * Encodes for gene tuberin- a tumor supressor gene * Both genes inhibit the mammalian large of rapamycin (mTOR) pathway ====Resources==== * [[https://www.ncbi.nlm.nih.gov/books/NBK1220/|Tuberous Sclerois Complex in Gene Reviews]] * [[https://1drv.ms/b/c/31d83ae8e55e0542/EVD_lW3jlI1Hl-7598XM2iMBGFZ1InOEprGzgt5JpvlOBw?e=uMxmAq | Hodgson N et al. Ophthalmic manifestations of tuberous sclerosis: a review. Clinical and Experimental Ophthalmology 2017;45:81-86]] * [[https://1drv.ms/b/c/31d83ae8e55e0542/EbK3lI7wIf1Fs2bMrAdeMzoBIWMDSLAcNTl04LrjuawFSA?e=2iRKDA|Larson, SA. Lecture: Peditric Primary Intraocular Tumors ]] {{tag>syndrome phakomatosis}} syndrome phakomatosis